Article
Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease.
BMC cardiovascular disorders - 30 Dec 2022
Zhang Yan-Jiao, Li Dong-Jie, Li Zhong-Yi, Hu Xiao-Lei, Li He, Ma Qi-Lin, Chen Xiao-Ping
Abstract excerpt
BACKGROUNDS: Remarkable interindividual variability in clopidogrel response is observed, genetic polymorphisms in P2RY12 and its signal pathway is supposed to affect clopidogrel response in CHD patients. METHODS: 539 CHD patients treated with clopidogrel were recruited. The platelet reaction index (PRI) indicated by VASP-P level were detected in 12-24 h after clopidogrel loading dose or within 5-7 days after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
